Liraglutide 6mg/mL, 3mL Injection

Liraglutide 6mg/mL, 3mL is a GLP-1 receptor agonist used in type 2 diabetes. It improves glucose control and can reduce cardiovascular risk in eligible patients.
Inject subcutaneously once daily at a consistent time, independently of meals. Dose escalation is gradual to improve gastrointestinal tolerability; rotate injection sites.
Liraglutide increases glucose-dependent insulin release, reduces glucagon secretion and slows gastric emptying while increasing satiety.
Nausea, vomiting, diarrhoea, constipation and reduced appetite are common. Pancreatitis, gallbladder problems and dehydration are important risks.
The 6mg/mL concentration is not the amount administered each day. Insulin or sulfonylurea treatment can increase hypoglycaemia risk when used alongside liraglutide.
Improves blood-glucose regulation and can support weight reduction through appetite and gastric-emptying effects.
No. It is the concentration in the device; the daily dose is a separately selected amount.
No. Liraglutide is administered daily, unlike several other GLP-1 medicines.
Slow escalation reduces nausea and other gastrointestinal effects.
No. It does not replace the insulin required in type 1 diabetes.
GLP-1: a gut hormone involved in glucose and appetite regulation. Satiety: the feeling of fullness. Gastric emptying: movement of food from the stomach.; AR: Liraglutide 6mg/mL, 3mL حقن; FR: Liraglutide 6mg/mL, 3mL injection; PT: Liraglutide 6mg/mL, 3mL injeção; ES: Liraglutide 6mg/mL, 3mL inyección; RU: Liraglutide 6mg/mL, 3mL инъекция; ID: Liraglutide 6mg/mL, 3mL injeksi; VI: Liraglutide 6mg/mL, 3mL thuốc tiêm; MS: Liraglutide 6mg/mL, 3mL suntikan; TL: Liraglutide 6mg/mL, 3mL iniksyon; ZH-SG: Liraglutide 6mg/mL, 3mL 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Liraglutide 6mg/mL, 3mL Injection under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Liraglutide 6mg/mL, 3mL Injection